Company Analysis

Cel-Sci Corporation (CVM)

NYSE: CVM · Biological Products, (No Diagnostic Substances) · Vienna, VA · filing with the SEC since 1996
Grade4.2
◀ Past 2.4● Present 4.3▶ Future 5.1
3 est.

Who owns Cel-Sci Corporation

As filed with the SEC
Holders of 5% or more
1
Lincoln Alternative Strategies LLC holds 6.94% of Common Stock, par value $0.01 per share, as its SCHEDULE 13G filed Aug 29, 2025 says.
Directors and officers
6
report now, of 12 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Lincoln Alternative Strategies LLC
SCHEDULE 13G · filed Aug 29, 2025 · Common Stock, par value $0.01 per share
6.94%
What CVM reports owning in othersstakes of 5% or more, and other ties
Cel-Sci Corporation reports no stake in another company in the record.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$900,000bought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
1718192021242526
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 12 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Kersten Geert RChief Executive Officer0$005$900,000
SI Assistanton CVM · research, not advice